Fundraising FoxBiokine
Jerusalem, IL · 1 known investors
Find your way into Biokine
Sign up to find every way you can get introduced to Biokine
- Your email: who you already know at Biokine, and who your contacts know
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Biokine team
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
BioKine develops immunotherapy drug candidates targeting cancer metastasis and treatment resistance, with its lead product BL-8040 in multiple clinical trials including stem cell mobilization, acute myeloid leukemia, and pancreatic carcinoma.
Founders & leadership
AP
Amnon PeledCEO/CSO
SC
Simone CabillyChief Scientist
Investors · 1
Frequently asked questions
- What does Biokine do?
- BioKine develops immunotherapy drug candidates targeting cancer metastasis and treatment resistance, with its lead product BL-8040 in multiple clinical trials including stem cell mobilization, acute myeloid leukemia, and pancreatic carcinoma.
- Who founded Biokine?
- Biokine was founded by Amnon Peled.
- Who are Biokine's investors?
- Biokine's investors include Clal Biotechnology Industries.
- Where is Biokine headquartered?
- Biokine is headquartered in Jerusalem, IL.